Orthocell Ltd

OCC · AU · Healthcare / Biotechnology

0.56AUD-0.01 (-2.61%)

Price History

Full chart

Market Stats

Previous Close0.575

Open0.575

Day Range0.555 – 0.58

52-Week Range0.67 – 1.59

Volume347.02K

Market Cap207.02M

P/E (TTM)0.00

Forward P/E0.00

EPS-0.05

Dividend Yield0.00%

Beta-0.06

50-Day Avg0.7452

200-Day Avg0.8358

About

Orthocell Limited, a regenerative medicine company, develops and commercializes cell therapies and biological medical devices for the repair of various bone and soft tissue injuries in Australia and internationally. It offers Ortho Autologous Chondrocyte Implantation, a cartilage cell therapy for treatment of articular cartilage defects in the knee and ankle; OrthoATI, for treatment of chronic tendon injuries; Striate+, a resorbable collagen membrane used for guided bone and tissue regeneration in dental applications; and Remplir, a collagen scaffold used in peripheral nerve repair. The company also develops Collagen Medical Device platform products for bone, nerve, tendon, muscle, or scar tissue, and ligament repair; and Tendon Cell Therapy for rotator cuff and lateral epicondyle indications. Orthocell Limited was incorporated in 2006 and is headquartered in Murdoch, Australia.

Company Details

SectorHealthcare
IndustryBiotechnology
CEOMr. Paul Frederick Anderson
Employees0
Headquarters161 Campus Drive, Murdoch, WA, Australia, 6150, Australia
Websitehttps://orthocell.com

Leadership

Mr. Paul Frederick AndersonCEO, MD & Executive Director · b. 1966
Mr. Jim PiperChief Financial Officer
Mr. Alex McHenryChief Operating Officer
Prof. Ming Hao ZhengChief Scientific Officer and Member of Medical & Scientific Advisory Board
Mr. Tony MacintyreChief Technical Operations Officer
Mr. Adam WoodChief Commercial Officer
Mr. Peter Gordon Webse B.Bus, FCIS, FCPA, FGIA, M.A.I.C.D.Company Secretary · b. 1963
John WalkerVice President of Sales USA

Financials

Income Statement

Currency: AUD	2010-06-30	2011-06-30	2012-06-30	2013-06-30	2014-06-30	2015-06-30	2016-06-30	2017-06-30	2018-06-30	2019-06-30	2020-06-30	2021-06-30	2022-06-30	2023-06-30	2024-06-30	2025-06-30	2026-06-30
Total Revenue	362.00K	798.00K	458.00K	524.28K	691.40K	790.43K	666.50K	529.82K	619.18K	945.66K	719.52K	1.02M	1.53M	4.24M	5.32M	7.55M	11.41M
Growth (%)	-	+120.44%	-42.61%	+14.47%	+31.88%	+14.32%	-15.68%	-20.51%	+16.87%	+52.73%	-23.91%	+41.48%	+50.47%	+177.01%	+25.27%	+42.05%	+51.07%
Cost of Revenue	65.00K	266.00K	324.00K	482.17K	597.15K	652.86K	497.59K	438.14K	469.89K	732.34K	725.92K	718.08K	699.20K	1.18M	1.63M	2.75M	7.73M
Gross Profit	-	-	-	42.11K	94.25K	137.57K	168.91K	91.68K	149.29K	213.32K	-6.40K	299.88K	832.52K	3.06M	3.69M	4.80M	3.68M
Gross Margin	-	-	-	8.03%	13.63%	17.40%	25.34%	17.30%	24.11%	22.56%	-0.89%	29.46%	54.35%	72.13%	69.39%	63.63%	32.24%
Operating Expense	-	-	-	1.39M	2.82M	5.16M	5.52M	6.26M	8.18M	8.73M	9.46M	11.97M	12.36M	13.37M	15.37M	18.78M	22.06M
Operating Income	-	-	-	-1.35M	-2.73M	-5.02M	-5.35M	-6.16M	-8.03M	-8.52M	-9.47M	-11.67M	-11.52M	-10.31M	-11.68M	-13.98M	-18.38M
Operating Margin	-	-	-	-257.09%	-394.52%	-635.59%	-803.37%	-1163.51%	-1297.18%	-900.57%	-1316.07%	-1146.34%	-752.40%	-242.98%	-219.76%	-185.09%	-161.15%
EBITDA	-	-	-	-1.30M	-3.31M	-5.80M	-5.81M	-6.52M	-8.29M	-8.53M	-9.25M	-11.67M	-11.52M	-10.34M	-11.68M	-13.43M	-17.52M
EBITDA Margin	-	-	-	-248.62%	-478.10%	-733.83%	-872.22%	-1231.45%	-1339.32%	-902.27%	-1286.25%	-1146.34%	-752.40%	-243.70%	-219.76%	-177.84%	-153.58%
Net Income	-	-	-	-1.32M	-2.18M	-3.74M	-3.78M	-4.18M	-5.76M	-5.85M	-6.15M	-9.04M	-9.11M	-6.25M	-7.18M	-8.57M	-13.91M
Net Income Margin	-	-	-	-252.41%	-315.62%	-473.50%	-567.87%	-788.46%	-929.80%	-618.85%	-854.88%	-887.76%	-594.53%	-147.26%	-135.10%	-113.46%	-121.98%
R&D	204.00K	177.00K	344.00K	450.75K	686.12K	733.08K	3.37M	3.91M	4.63M	5.59M	5.47M	7.34M	6.82M	7.60M	8.67M	8.82M	4.02M
R&D as % of Total Revenue	56.35%	22.18%	75.11%	85.98%	99.24%	92.74%	505.48%	738.79%	748.51%	590.61%	760.17%	721.38%	445.14%	179.07%	163.19%	116.79%	35.26%
Interest Expense	0	0	0	0	0	0	0	0	0	370.74K	459.84K	673.52K	84.13K	30.57K	60.52K	-	-
Interest Expense % of Total Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	39.20%	63.91%	66.16%	5.49%	0.72%	1.14%	-	-

Balance Sheet

Currency: AUD	2010-06-30	2011-06-30	2013-06-30	2014-06-30	2015-06-30	2016-06-30	2017-06-30	2018-06-30	2019-06-30	2020-06-30	2021-06-30	2022-06-30	2023-06-30	2024-06-30	2025-06-30	2026-06-30
Total Assets	1.52M	1.91M	1.76M	5.14M	6.54M	7.11M	7.16M	5.23M	13.60M	23.17M	19.33M	37.90M	29.61M	26.62M	35.24M	54.81M
Total Liabilities	205.00K	343.00K	687.24K	5.06M	2.15M	2.23M	2.45M	2.86M	2.87M	2.27M	2.46M	27.99M	23.46M	22.08M	20.67M	20.40M
Total Equity	1.31M	1.57M	214.08K	76.19K	4.38M	4.88M	4.71M	2.37M	10.72M	20.90M	16.87M	9.90M	6.15M	4.53M	14.57M	34.41M
Cash	212.00K	559.00K	591.14K	3.47M	4.77M	5.18M	5.05M	2.91M	11.24M	20.44M	16.33M	11.02M	24.82M	20.61M	28.62M	9.45M
Total Debt	-	-	-	-	-	-	-	-	500.89K	500.89K	621.73K	507.56K	562.31K	689.69K	576.89K	1.55M
Net Debt	-	-	-591.14K	-3.47M	-4.77M	-5.18M	-5.05M	-2.91M	-11.24M	-19.94M	-15.71M	-10.51M	-24.26M	-19.92M	-28.04M	-7.90M

Cash Flow

Currency: AUD	2010-06-30	2011-06-30	2013-06-30	2014-06-30	2015-06-30	2016-06-30	2017-06-30	2018-06-30	2019-06-30	2020-06-30	2021-06-30	2022-06-30	2023-06-30	2024-06-30	2025-06-30	2026-06-30
Operating Cash Flow	-	-	-290.57K	-1.75M	-2.77M	-3.32M	-3.56M	-4.64M	-4.18M	-5.26M	-4.63M	-6.26M	14.59M	-6.51M	-8.68M	-13.32M
Investing Cash Flow	-	-	-100.06K	-273.25K	-319.35K	-328.27K	-363.49K	-373.56K	-368.74K	-55.20K	-188.52K	-535.02K	-631.56K	-942.02K	-359.06K	-36.97M
Financing Cash Flow	-	1.18M	-66.42K	4.90M	4.39M	4.06M	3.78M	2.88M	12.88M	14.52M	709.15K	1.49M	-164.61K	3.24M	17.05M	31.12M
Capital Expenditure	73.00K	30.00K	17.22K	4.87K	56.11K	40.96K	107.95K	87.18K	14.15K	55.20K	188.52K	535.02K	631.56K	942.02K	359.06K	1.11M
Free Cash Flow	-	-	-307.80K	-1.76M	-2.82M	-3.36M	-3.66M	-4.73M	-4.19M	-5.31M	-4.82M	-6.80M	13.96M	-7.45M	-9.04M	-14.43M
FCF to OCF	-	-	105.93%	100.28%	102.03%	101.23%	103.04%	101.88%	100.34%	101.05%	104.07%	108.54%	95.67%	114.48%	104.14%	108.33%

Earnings

Report Date	Feb 26, 2016	Sep 12, 2016	Feb 28, 2017	Sep 14, 2017	Feb 23, 2018	Aug 31, 2018	Feb 27, 2019	Aug 30, 2019	Feb 25, 2020	Aug 31, 2020	Feb 26, 2021	Aug 27, 2021	Feb 23, 2022	Aug 31, 2022	Feb 28, 2023	Aug 30, 2024	Nov 27, 2024	Feb 24, 2025	Aug 28, 2025	Dec 3, 2025
EPS Estimate	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00	-	0.00	0.00	0.00	0.00	-	0.00
EPS Actual	-0.03	-0.02	-0.03	-0.01	-0.01	-0.05	-0.01	-0.03	-0.01	-0.02	-0.02	-0.02	-0.02	-0.02	-0.02	0.00	0.00	-0.01	-0.03	0.00
Surprise	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Timing	-	-	-	-	-	-	-	-	-	-	-	-	-	Pre-market	Pre-market	-	-	-	Pre-market	-

Key Statistics & Ratios

Market Cap207.02M

Enterprise Value169.48M

Trailing P/E0.00

Forward P/E0.00

Price / Sales18.15

Price / Book6.17

EPS-0.05

Book Value0.126

Revenue (TTM)11.41M

Gross Profit (TTM)6.69M

EBITDA-17.78M

Profit Margin-121.98%

Operating Margin-159.76%

Return on Equity-56.82%

Return on Assets-25.52%

Shares Outstanding272.39M

Shares Float228.45M

Beta-0.06

Dividend Yield0.00%

Dividend Rate0.00

Payout Ratio0.00%